Please login to the form below
Last chance to register - Webinar: How to price a pharmaceutical product during a global economic recession
How can you ensure your product achieves optimal market access during a global economic recession?
Thursday 9th July at 2pm BST / 9am EST
Choosing a price for a new product, and then justifying that price to payers, is a challenge for all pharmaceutical and biotechnology companies. This challenge becomes even more difficult if you are launching a product during a global economic recession. A panel of experts in pricing, chaired by our Senior Executive Advisor, Raf De Wilde, will discuss how best to navigate these pricing challenges and make sure you achieve the optimal price for your product.
Sign up for this webinar now here.
The panel for this webinar consists of:
- Anusha Patel, High Cost Medicines and Regional Homecare Lead Pharmacist for the East Midlands; Advisor to NICE and NHS England
- Bertrand Tardivel Former Head of Global Pricing at Takeda; founder of Freh
- Jaime Espin Former Member of the WHO Guideline Panel on Country Pharmaceutical Pricing Policies, and pricing advisor to the European Commission
Company Details
Valid Insight
+44 (0) 20 3750 9833
Address:
152-160 City Road
Kemp House
London
EC1V 2NX
United Kingdom
Latest content on this profile
- Webinar: The value and effective use of RWE in pricing and market access
Valid Insight
- Valid Insight are hiring for Consultants in Value Communication (mid to senior levels)
- New role available for Consultants in Value Communication with experience in market access writing and value communication.
Valid Insight
- Webinar: Maintaining market access through a pandemic, 6 months on
- In this webinar, Valid Insight explore market access and how it has evolved through a pandemic over the past 6 months.
Valid Insight
- Webinar: How to develop an optimal value story for your product
- This webinar is part of the ongoing expert insights series run by Valid Insight
Valid Insight
- Last chance to register - Webinar: How to price a pharmaceutical product during a global economic recession
- How can you ensure your product achieves optimal market access during a global economic recession?
Valid Insight
- Are biobetters a market access opportunity?
- Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen.
Valid Insight
